Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA to consider annual or biannual partnership meetings with industry, consumers.

This article was originally published in The Tan Sheet

Executive Summary

FDA WILL CONSIDER REGULAR PARTNERSHIP MEETINGS WITH INDUSTRY, CONSUMERS as a result of concerns raised by representatives of the pharmaceutical industry, academia, consumer groups and state and federal regulators at the agency's "grassroots regulatory partnership meetings" held in five regional locations across the country during the last week of April. Improved and consistent agency communication was a common theme of the half-day public sessions.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel